Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Coronaviruses (CoVs) typically affect the respiratorytract of mammals, including humans, and lead to mild to severe respiratory tract infections1. In the past two decades, two highly pathogenic human CoVs (HCoVs).

Descargar PDF